Cardiio
Cardiio is a Cambridge, MA-based health technology company founded in 2012 that develops intelligent sensor-based algorithms for wellness, fitness, and chronic disease monitoring. The 1-10 employee firm originated at MIT Media Lab and has disclosed only seed and grant funding.
- Company typePrivate
- Founded2012
- HeadquartersCambridge, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What Cardiio does
Cardiio is a Cambridge, Massachusetts-based for-profit health technology company founded in 2012. Per its self-description, it develops intelligent algorithms for monitoring wellness, fitness, and chronic diseases using sensors, suggesting a focus on signal-processing or computer-vision techniques applied to biosignal data (such as heart rate derived from camera input). The company was incubated at the MIT Media Lab, which provides the technical and academic provenance for its algorithmic approach, and it received early-stage backing from digital-health-focused Rock Health Capital and a non-dilutive grant from the National Science Foundation in 2015.
The company's documented commercial footprint is minimal: headcount is reported at 1-10 employees, total disclosed funding since inception is approximately $170,000, and no products, pricing, customers, partnerships, or revenue figures are present in the source material. There is no public mobile app, API, or SDK, and the firmographic profile is consistent with a research-oriented or dormancy-stage entity rather than an actively scaling commercial venture. The combination of biosignal algorithm expertise, MIT pedigree, and anemic disclosed capital and customer activity makes Cardiio a pre-commercial or stealth-stage health AI asset as represented in the available data.
Cardiio firmographics
Firmographics- Name
- Cardiio
- Website
- https://cardiio.com
- Company type
- Private
- Founded year
- 2012
- Headcount range
- 1–10 employees
- Short description
- Cardiio is a Cambridge, MA-based health technology company founded in 2012 that develops intelligent sensor-based algorithms for wellness, fitness, and chronic disease monitoring. The 1-10 employee firm originated at MIT Media Lab and has disclosed only seed and grant funding.
- Ownership category
- akta.pro rank
Cardiio industry classification
Industry- Product category
- Digital Health Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
- akta.pro secondary industries
- Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
Keywords
Where Cardiio is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Markets served
Cardiio business model
Business model- GTM type
- B2C
- Offering type
- Software
Cardiio product offering
Product offeringCore offering
Cardiio develops intelligent algorithms for the monitoring of wellness, fitness, and chronic diseases using sensors. The company applies computational techniques to biosignal data captured through sensors to enable non-invasive, continuous health tracking for individual users.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiio Intelligent Health Monitoring Software offering built on intelligent algorithms that process sensor data to monitor wellness, fitness, and chronic disease indicators for individual consumer users.
Companies that use Cardiio
Customer profileIdeal customer profiles1 record
Cardiio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Cardiio partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights1 record
Cardiio competitors and assessment
Company assessmentDirect peers
- iRhythm Technologies: iRhythm's Zio patch and AI-based arrhythmia detection platform is a clinical-grade cardiac ambulatory monitoring service. It represents the regulated, chronic-disease endpoint of the same cardiac monitoring category Cardiio's algorithms target.
- AliveCor: AliveCor (KardiaMobile) is a leading consumer and clinical ECG/cardiac monitoring company. Its single-lead ECG hardware plus AI algorithm approach targets the same chronic-disease cardiac monitoring segment Cardiio addresses, though AliveCor uses dedicated hardware.
- Eko Health: Eko combines digital stethoscopes and sensors with AI algorithms for cardiac and pulmonary monitoring. Its sensor-plus-algorithm model and chronic disease focus make it a strong analog to Cardiio's intelligent-algorithms-for-sensors positioning.
- Binah.ai: Binah.ai builds contactless vital-sign monitoring software using smartphone camera PPG, the same underlying signal-extraction approach as Cardiio. It targets wellness, fitness, and remote patient monitoring use cases via SDK licensing, making it the closest direct competitor.
- Nuralogix: Nuralogix's Anura platform performs contactless health measurements (heart rate, stress, blood pressure) via video, sharing Cardiio's camera-based PPG foundation. It is pursuing both consumer wellness and clinical monitoring applications, directly overlapping Cardiio's stated scope.
Broad incumbents
- Withings: Withings makes connected health devices (smart scales, watches, blood pressure monitors) with embedded cardiac and wellness algorithms. As a broader consumer health incumbent, it overlaps Cardiio on wellness/fitness monitoring using sensors.
- Fitbit (Google): Fitbit, now part of Google, ships wearable sensors with heart-rate, sleep, and fitness algorithms to tens of millions of users. It is a broad incumbent in the sensor-based wellness and fitness monitoring market where Cardiio also operates.
- Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, provides remote cardiac monitoring services using wearable biosensors and proprietary algorithms. It represents a scaled, regulated, cardiac-RPM incumbent with similar chronic-disease monitoring use cases to Cardiio.
- Apple (Apple Watch / Health): Apple's Watch and Health platforms include heart-rate, ECG, and atrial fibrillation detection algorithms embedded in consumer hardware at massive scale. Apple defines the upper bound of competition for any consumer-facing cardiac monitoring algorithm.
Emerging players
- Biobeat: Biobeat offers wearable and contactless remote patient monitoring patches with AI-based vital-sign analytics for hospital and chronic-disease use. It is comparable to Cardiio's chronic-disease monitoring ambitions but currently centered on dedicated sensor hardware.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Cardiio social profiles
Digital presenceCardiio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cardiio leadership team
Management profileNumber of profiles
Cardiio funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cardiio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cardiio
What does Cardiio do?
Cardiio develops intelligent algorithms for the monitoring of wellness, fitness, and chronic diseases using sensors. The company applies computational techniques to biosignal data captured through sensors to enable non-invasive, continuous health tracking for individual users.
When was Cardiio founded?
Cardiio was founded in 2012. It employs 1 to 10 people.
Where is Cardiio based?
Cardiio is headquartered in Cambridge, United States, in the North America region.
Who are Cardiio's main competitors?
Direct peers on record are iRhythm Technologies, AliveCor, Eko Health, Binah.ai and Nuralogix. Broad incumbents are Withings, Fitbit (Google), Preventice Solutions (Boston Scientific) and Apple (Apple Watch / Health). Biobeat is listed as an emerging player.
Does Cardiio have an API?
No public API is recorded for Cardiio.
What industry is Cardiio in?
Cardiio's product category is Digital Health Monitoring. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLAHACAI, Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking). Its NAICS code is 334510 and its SIC code is 3829.